dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Le, Dung T. |
dc.contributor.author | Kim, Tae Won |
dc.contributor.author | Van Cutsem, Eric |
dc.contributor.author | Geva, Ravit |
dc.contributor.author | Jäger, Dirk |
dc.contributor.author | Hara, Hiroki |
dc.contributor.author | Elez Fernandez, Mª Elena |
dc.date.accessioned | 2021-08-23T09:56:23Z |
dc.date.available | 2021-08-23T09:56:23Z |
dc.date.issued | 2020-01-01 |
dc.identifier.citation | Le DT, Kim TW, Cutsem E Van, Geva R, Jäger D, Hara H, et al. Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164. J Clin Oncol. 2020 Jan 1;38(1):11-19. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/6229 |
dc.description | Pembrolizumab; Càncer colorectal |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;38(1) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer |
dc.subject | Recte - Càncer |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Neoplasm Metastasis |
dc.title | Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164 |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.19.02107 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | metástasis neoplásica |
dc.relation.publishversion | https://ascopubs.org/doi/10.1200/JCO.19.02107 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Le DT] Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD. [Kim TW] Asan Medical Center, Seoul, Republic of Korea. [Van Cutsem E] University Hospitals Gasthuisberg Leuven, KU Leuven, Leuven, Belgium. [Geva R] Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. [Jäger D] Nationales Centrum Tumorerkrankungen, Heidelberg, Germany. [Hara H] Saitama Cancer Center, Saitama, Japan. [Elez E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 31725351 |
dc.identifier.wos | 000538777900002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |